Clinical Trials for Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy

NCT ID: NCT06994650

This clinical trial is studying a new treatment called HRS-9531 injection for patients who have both obstructive sleep apnea (OSA) and obesity. OSA is a condition where a person has trouble breathi...